Corrigendum to “Molecular modeling and 3D-QSAR studies of indolomorphinan derivatives as kappa opioid antagonists” [Bioorg. Med. Chem. 14 (2006) 601–610]

Corrigendum to “Molecular modeling and 3D-QSAR studies of indolomorphinan derivatives as kappa opioid antagonists” [Bioorg. Med. Chem. 14 (2006) 601–610]

Bioorganic & Medicinal Chemistry 14 (2006) 1671 Corrigendum Corrigendum to ‘‘Molecular modeling and 3D-QSAR studies of indolomorphinan derivatives a...

57KB Sizes 2 Downloads 71 Views

Bioorganic & Medicinal Chemistry 14 (2006) 1671

Corrigendum

Corrigendum to ‘‘Molecular modeling and 3D-QSAR studies of indolomorphinan derivatives as kappa opioid antagonists’’ [Bioorg. Med. Chem. 14 (2006) 601–610] Wei Li,a Yun Tang,a,b,* You-Li Zhenga and Zhui-Bai Qiua,* a

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, 138 Yixueyuan Road, Shanghai 200032, China b School of Pharmacy, East China University of Science & Technology, 130 Meilong Road, Shanghai 200237, China Available online 5 January 2006

On page 602, in Figure 1, structure 4 (KAA-1) is incorrect. The corrected Figure 1 is given here.

Figure 1. Some potent highly selective kappa antagonists reported recently.

DOI of original article: 10.1016/j.bmc.2005.08.052. * Corresponding authors. Fax: +86 21 54237264; e-mail addresses: [email protected]; [email protected] 0968-0896/$ - see front matter Ó 2005 Elsevier Ltd. All rights reserved. doi:10.1016/j.bmc.2005.12.026